comparemela.com

Latest Breaking News On - Light asset management - Page 4 : comparemela.com

SI-BONE, Inc (NASDAQ:SIBN) Receives Average Rating of Buy from Analysts

SI-BONE, Inc (NASDAQ:SIBN) Receives Average Rating of Buy from Analysts
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

NeoGenomics (NASDAQ:NEO) Research Coverage Started at Craig Hallum

NeoGenomics (NASDAQ:NEO) Research Coverage Started at Craig Hallum
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Alphatec Holdings, Inc (NASDAQ:ATEC) Receives Consensus Recommendation of Buy from Analysts

Alphatec Holdings, Inc. (NASDAQ:ATEC – Get Free Report) has been assigned an average rating of “Buy” from the seven analysts that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued ratings on the stock in the […]

NeoGenomics (NASDAQ:NEO) Trading Down 7 7% After Analyst Downgrade

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) were down 7.7% on Tuesday after Needham & Company LLC lowered their price target on the stock from $24.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock. NeoGenomics traded as low as $13.70 and last traded at $14.05. Approximately 252,873 […]

Olema Pharmaceuticals, Inc (NASDAQ:OLMA) Receives $21 43 Average PT from Brokerages

Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have earned a consensus recommendation of “Buy” from the eight brokerages that are covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the stock […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.